MOH Molina Healthcare Inc Common Stock
NYSE · Health Care · SEC EDGAR에서 보기 ↗ 종가 10월 2, 2026 10-K/10-Q 7월 23, 2026MOH 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
MOH 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
막대 세분성은 선택한 기간에 따라 조정됩니다. 막대의 시가/고가/저가/종가를 보려면 차트에 마우스를 올리세요.
| 배당락일 | 분할 | 유형 |
|---|---|---|
| 2011년 5월 23일 | 3-for-2 | 정방향 |
Molina Healthcare Inc Common Stock 정보 위키백과 회사 개요
Molina Healthcare, Inc. is an American managed care company headquartered in Long Beach, California. The company provides health insurance to individuals through government programs such as Medicaid and Medicare.
History
Molina Healthcare was founded in 1980 by C. David Molina, an emergency room physician in Long Beach, California. He had seen an influx of patients using the emergency room for common illnesses such as a sore throat or the flu because they were being turned away by doctors who would not accept Medi-Cal. Molina established his first primary care clinic with the goal of treating the lowest-income patients, regardless of their ability to pay.
Leadership
For twenty years, the company was run by Dr. Molina's son, J. Mario Molina, MD, a physician. He was the president and CEO of the company. John Molina, Mario's younger brother, was the CFO of Molina Healthcare. The two took over Molina's operations after their father died in 1996 and continued to expand the company. In May 2017 Dr. J. Mario Molina and John Molina were removed from their positions by the Board of Directors, who cited poor financial performance as the reason for the change in leadership. Though the board also discused their displeasure in the CEO and CFO criticising President Donald Trump.[3][4] In October 2017 the company announced Joseph Zubretsky, the former CFO of Aetna, as Molina Healthcare's president and CEO.
Clinics
The first Molina Medical clinic was opened in Wilmington, California in 1980. The company formerly operated clinics in Washington, New Mexico, Florida and Utah. The clinics were opened to provide health care to low-income families and individuals. In August 2017 Molina Healthcare announced it would close several clinics in Michigan, Florida, New Mexico, Wisconsin, and Utah.
Becoming HMO
Molina Healthcare has focused on government-paid healthcare programs such as SCHIP and Medicaid since it became a health maintenance organization in 1985. From 1985 to 1997, the company was based solely in California.
Expansion of health plans
1997: Molina Healthcare acquires Health Reach Family Health Care and enters the states of Utah and Michigan.
2000: Molina Healthcare enters the state of Washington.
2004: Molina Healthcare enters the state of New Mexico.
2005: Molina Healthcare becomes a health plan in Ohio.
2006: Molina Healthcare enters the state of Texas.
2007: Molina Healthcare enters Missouri.
2008: Molina Healthcare enters Florida.
2010: Molina Healthcare enters Wisconsin.
2012: Molina Healthcare enters Illinois.
2013: Molina Healthcare enters South Carolina by acquiring assets from Community Health Solutions.
2013: Molina Healthcare acquires New Mexico Lovelace Medicaid contract.
2014: Molina Healthcare acquires Florida Medicaid assets from First Coast Advantage.
2015: Molina Healthcare enters Chicago market, acquiring MyCare Chicago's Medicaid assets.
2015: Molina Healthcare enters Puerto Rico.
2015: Molina Healthcare of Washington is the first health care company in the state to cover "Virtual Urgent Care" services.
2015: Molina Healthcare acquires Medicaid assets of Integral Health Plan, Inc. in Florida.
2015: Molina Healthcare acquires Providence Human Services and Community Services from Providence Service Corporation and renames them Pathways.
2015: Molina Healthcare adds online access to behavioral health.
2015: Molina Healthcare acquires HealthPlus MIChild and Medicaid programs of Michigan.
2015: Molina Healthcare acquires assets of Loyola Physician Partners' Medicaid Program of Illinois.
2017: Molina Healthcare exits the individual Marketplace in Utah and Wisconsin.
2018: Molina Healthcare loses Medicaid contract with the state of New Mexico.
2018: Molina Healthcare sells Pathways to Altar Capital
2019: Molina Healthcare loses Medicaid contract with the state of Texas.
2020: Molina Healthcare acquires Passport Health Plan in Kentucky.
2021: Molina Healthcare acquires Magellan Complete Care line of business from Magellan Health, Inc. With this acquisition, Molina enters Arizona, Massachusetts, and Virginia.
2021: Molina Healthcare acquires Affinity Health Plan in New York.
2021: Molina Healthcare acquires Cigna's Medicaid contracts in Texas.
2023: Molina Healthcare enters Iowa.
2023: Molina Healthcare loses Medicad contract with the state of Indiana.
2024: Molina Healthcare loses Medicaid contracts with the states of Virginia and Florida.
Going public
Molina Healthcare filed with the Securities and Exchange Commission for an initial stock offering in December 2002 and went public in July 2003 with a stock offering of $102 million. The shares were priced at $17.50, and Molina raised approximately $124 million in the initial public offering. In its stock market debut, Molina sold 6.6 million shares at $20.30, making the company the third-best first day gainer of 2003. Molina Healthcare was the first company from Inc. Magazine's "Inner City 100" list to go public.
Entering the Medicare market
Molina Healthcare entered the Medicare market in 2006. The company currently offers Medicare health plan options in: Arizona, California, Florida, Idaho, Illinois, Kentucky, Massachusetts, Michigan, Nevada, New Mexico, New York, Ohio, South Carolina, Texas, Utah, Virginia, Washington and Wisconsin.
Entering MMIS market
Molina Healthcare acquired Unisys' health information management business in December 2010 to create Molina Medicaid Solutions (MMS). MMS has Medicaid Management Information Systems (MMIS) contracts with Idaho, Louisiana, Maine, New Jersey, West Virginia and the U.S. Virgin Islands. In Autumn 2018, Molina Healthcare, Inc. sold its Medicaid management information systems business, Molina Medicaid Solutions (MMS), to DXC Technology. MMS was a wholly owned subsidiary of Molina Healthcare at the time of sale.
Entering health insurance marketplace
In 2014, Molina Healthcare began offering Marketplace plans in nine states where it offered Medicaid health plans through State Facilitated Marketplaces and Federally Facilitated Marketplace. On November 16, 2016 the Seattle Times reported that about 11 million people currently get their coverage through the exchange. In August 2017 Molina announced it would stop offering plans on the health insurance marketplaces in Utah, Wisconsin, and Maine in 2018.
Dual eligible demonstration projects
Molina was selected to participate in dual eligible demonstration projects in California, Ohio, Illinois, Michigan, South Carolina and Texas to serve patients who are eligible for both Medicare and Medicaid.
Criticism and controversies
A 2023 report investigating "High Rates of Prior
Authorization Denials" reported that Molina Healthcare's Medicaid plans for financially vulnerable people had some of the highest denial percentages in the country. It was reported, that Molina Healthcare operated plans that denied medical care under requests for prior authorization of services in more than 25% of cases in 2019. About 2.7 million people were enrolled in these plans at the time, while another 8.4 million people were enrolled in plans with denial rates higher than average at 15-25%. Some plans had even higher denial rates, as their Illinois plan 41% of requests.
Philanthropy
In May 2022, MolinaCares presented a $100,000 grant to support Compass Health's Broadway Campus Redevelopment Project. The grant will aid funding of construction of a 72,000 square-foot, state-of-the-art facility that will expand community-based behavioural health care services and its workforce in northwest Washington.
In August 2026, MolinaCares awarded a grant of $150,000 to literacy non-profit Indy Reads, to launch a new program in health literacy, in partnership with Molina Healthcare.
Awards and recognition
Molina Healthcare was awarded the 2011 Alfred P. Sloan Award for Business Excellence in Workplace Flexibility. The award ranked Molina Healthcare in the top 20 percent of employers nationally in terms of its programs, policies and culture for creating an effective and flexible workplace. In 2006, Molina Healthcare was named among the 100 best corporate citizens by Business Ethics magazine. In 2005, Time magazine recognized Dr. J. Mario Molina, then CEO of Molina Healthcare, as one of the 25 most influential Hispanics in America.
The company ranked 155th on the 2021 Fortune 500 list of the largest United States corporations by revenue. The company ranked 126th on the 2023 Fortune 500 list of the largest United States corporations by revenue.
Other awards and recognition
2014: Milwaukee Journal Sentinel Recognizes Molina Healthcare of Wisconsin with a Top Workplace Award 2014
2014: Molina Healthcare of New Mexico voted Best Places to Work by Albuquerque Business First
2014: Molina Healthcare was one of 26 companies to participate in President Obama's SupplierPay 2014
2015: Molina Healthcare voted Top Ten Least Stressful Companies to Work for In America 2015
2015: Molina Healthcare ranked 301 in top Fortune 500 2015
2016: Molina Healthcare ranked 201 in top Fortune 500 2016
2017: Molina Healthcare ranked 156 in Fortune 500 2017
2023: Molina Healthcare of Kentucky awarded One of Kentucky's Best Places to Work
2023: Molina Healthcare recognized as one of America's Best-in-State Employers by Forbes
2023: Molina Healthcare recognized as one of Time's World's Best Companies of 2023
2023: Molina Healthcare recognized as one of Newsweek's Greatest Workplaces for Parents and Families 2023
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
| 지표 | 5년 추세 | MOH | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| P/E (TTM) | 1053.05년 평균 ≈21.1 | ≈21.1 | 36.3 | 고평가 | |
| P/S (TTM) | 0.25년 평균 ≈0.5 | ≈0.5 | 0.7 | 저평가 | |
| P/B (MRQ) | 2.45년 평균 ≈4.3 | ≈4.3 | 3.9 | 저평가 | |
| EV / EBITDA (TTM) | 12.75년 평균 ≈7.0 | ≈7.0 | 16.1 | 저평가 | |
| 주가 / FCF (TTM) | 36.45년 평균 ≈14.4 | ≈14.4 | · | · | |
| 주가 / 현금 흐름 (TTM) | 27.05년 평균 ≈11.5 | ≈11.5 | · | · | |
| EV / 매출 (TTM) | 0.15년 평균 ≈0.3 | ≈0.3 | · | · | |
| EV / FCF (TTM) | 17.45년 평균 ≈10.3 | ≈10.3 | · | · | |
| Price / Tangible Book (주가 / 유형 장부 가치) | 5.35년 평균 ≈7.7 | ≈7.7 | · | · |
동종 기업 중앙값은 지표별로 표준화된 기준으로 계산되며, 이 주식에 표시된 TTM/MRQ 기준과 항상 일치하지 않을 수 있습니다.
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
| 지표 | 5년 추세 | MOH | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| 영업이익률 (TTM) | 0.46%5년 평균 ≈3.6% | ≈3.6% | 3.5% | 약함 | |
| EBITDA 마진 (TTM) | 0.83%5년 평균 ≈4.1% | ≈4.1% | 3.7% | 약함 | |
| 세전 마진 (TTM) | -0.01%5년 평균 ≈3.2% | ≈3.2% | 2.8% | 약함 | |
| 순이익률 (TTM) | -0.02%5년 평균 ≈2.4% | ≈2.4% | 2.9% | 약함 | |
| ROA (TTM) | -0.04%5년 평균 ≈6.3% | ≈6.3% | 3.0% | 동일 | |
| ROE (TTM) | -0.16%5년 평균 ≈23.1% | ≈23.1% | 10.1% | 동일 | |
| ROIC | 8.0%5년 평균 ≈15.3% | ≈15.3% | 8.0% | 동일 |
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
| 지표 | 5년 추세 | MOH | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 (MRQ) | 0.95년 평균 ≈0.7 | ≈0.7 | 0.7 | 높은 부채 | |
| 유동비율 (MRQ) | 1.75년 평균 ≈1.5 | ≈1.5 | 1.7 | 동일 | |
| 당좌 비율 (MRQ) | 1.65년 평균 ≈1.5 | ≈1.5 | 1.3 | 강한 유동성 | |
| 장기 부채 / 자기 자본 (MRQ) | 0.95년 평균 ≈0.7 | ≈0.7 | 0.7 | 높은 부채 |
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
| 지표 | 5년 추세 | MOH | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| Revenue YoY (매출 YoY) | 11.8%5년 평균 ≈19.1% | ≈19.1% | · | · | |
| Revenue CAGR 3Y (매출 CAGR 3년) | 12.4%5년 평균 ≈15.5% | ≈15.5% | · | · | |
| Revenue CAGR 5Y (매출 CAGR 5년) | 18.5% | · | · | · | |
| EPS YoY | -56.3%5년 평균 ≈2.3% | ≈2.3% | · | · | |
| Net Income YoY (순이익 YoY) | -60.0%5년 평균 ≈0.79% | ≈0.79% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3년) | -13.0%5년 평균 ≈9.2% | ≈9.2% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5년) | -4.5% | · | · | · | |
| Net Income CAGR 3Y (순이익 CAGR 3년) | -15.8%5년 평균 ≈7.7% | ≈7.7% | · | · | |
| Net Income CAGR 5Y (순이익 CAGR 5년) | -6.9% | · | · | · |
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
| 지표 | 5년 추세 | MOH | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| Asset Turnover (자산 회전율) | 2.95년 평균 ≈2.6 | ≈2.6 | 2.4 | 최상위권 | |
| Receivables Turnover (매출 채권 회전율) | 13.35년 평균 ≈13.5 | ≈13.5 | 16.3 | 평균 이하 | |
| Revenue / Employee (연간 매출액 ÷ 직원 수(yfinance 보고 인원수). 파생 — 저장된 SEC-XBRL 개념이 아님.) | ≈$2.4M | · | · | · |
가치 · ≈ 5년 평균 · 산업 중앙값 · 중앙값 대비 평가
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | 보고서 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|---|
| 2026년 6월 30일 | 7월 21, 2026 | $1.51 | $1.40 | 7.5% |
| 2026년 3월 31일 | $2.35 | $1.94 | 21.0% | |
| 2025년 12월 31일 | $-2.75 | $0.34 | -916.0% | |
| 2025년 9월 30일 | $1.84 | $3.94 | -53.3% | |
| 2025년 6월 30일 | $5.48 | $5.85 | -6.3% | |
| 2025년 3월 31일 | $6.08 | $6.02 | 1.1% |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B | $16.83B | $18.89B | $19.88B | $17.78B | $14.18B | $9.67B | |
| Cost of Revenue | $39.49B | $34.43B | $28.67B | $27.18B | $23.70B | $15.82B | $13.90B | · | · | · | · | · | |
| Gross Profit | · | · | · | · | · | $2.48B | $2.30B | $2.52B | $1.81B | $1.73B | $1.53B | $1.00B | |
| SG&A Expense | $3.01B | $2.74B | $2.46B | $2.31B | $2.07B | $1.48B | $1.30B | $1.33B | $1.59B | $1.39B | $1.15B | $765M | |
| Operating Expenses | $44.65B | $38.94B | $32.50B | $30.80B | $26.75B | $18.34B | $15.79B | $17.76B | $20.44B | $17.48B | $13.79B | $9.47B | |
| Operating Income | $781M | $1.71B | $1.57B | $1.17B | $1.02B | $1.08B | $1.04B | $1.13B | $-555M | $306M | $387M | $193M | |
| Interest Expense | · | · | $109M | $110M | $120M | $102M | $87M | $115M | $118M | $101M | $66M | $57M | |
| Interest Income | · | · | · | $75M | $77M | $17M | $17M | $125M | $70M | $38M | $23M | $20M | |
| Other Non-op | · | · | $0 | $0 | $-25M | $-15M | $15M | $-17M | $61M | $0 | $1M | $-1M | |
| Pretax Income | $589M | $1.59B | $1.46B | $1.06B | $875M | $961M | $972M | $999M | $-612M | $205M | $322M | $135M | |
| Income Tax | $117M | $410M | $373M | $271M | $216M | $288M | $235M | $292M | $-100M | $153M | $179M | $73M | |
| Net Income | $472M | $1.18B | $1.09B | $792M | $659M | $673M | $737M | $707M | $-512M | $52M | $143M | $62M | |
| EPS (Basic) | $8.93 | $20.52 | $18.91 | $13.72 | $11.40 | $11.40 | $11.85 | $11.57 | $-9.07 | $0.93 | $2.75 | $1.33 | |
| EPS (Diluted) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 | $2.58 | $1.29 | |
| Shares (Basic) | 52,800,000 | 57,400,000 | 57,700,000 | 57,800,000 | 57,800,000 | 59,000,000 | 62,200,000 | 61,000,000 | 56,000,000 | 55,400,000 | 52,000,000 | 47,000,000 | |
| Shares (Diluted) | 52,900,000 | 57,700,000 | 58,100,000 | 58,500,000 | 58,600,000 | 59,900,000 | 64,200,000 | 67,000,000 | 56,000,000 | 56,000,000 | 56,000,000 | 48,000,000 | |
| EBITDA | $976M | $1.89B | $1.74B | $1.35B | $1.15B | $1.17B | $1.13B | $1.26B | $-377M | $488M | $513M | $327M |
대차대조표
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.25B | $4.66B | $4.85B | $4.01B | $4.44B | $4.15B | $2.45B | $2.83B | $3.19B | $2.82B | $2.33B | $1.54B | |
| Short-term Investments | $4.01B | $4.33B | $4.26B | $3.50B | $3.20B | $1.88B | $1.95B | $1.68B | $2.52B | $1.76B | $1.80B | $1.02B | |
| Receivables | $3.53B | $3.30B | $3.10B | $2.30B | $2.18B | $1.67B | $1.41B | $1.33B | $871M | $974M | $597M | $596M | |
| Prepaid Expense | $655M | $487M | $331M | $277M | $247M | $175M | $163M | $149M | $239M | $131M | $192M | $49M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $51M | |
| Current Assets | $12.44B | $12.77B | $12.54B | $10.08B | $10.06B | $7.88B | $5.97B | $6.46B | $7.51B | $5.99B | $5.31B | $3.20B | |
| PP&E (Net) | · | · | · | · | · | · | · | $241M | $342M | $454M | $393M | $341M | |
| PP&E (Gross) | $1.11B | $1.03B | $932M | $882M | $822M | $752M | $687M | $774M | $883M | $919M | $755M | $618M | |
| Accum. Depreciation | $875M | $806M | $729M | $695M | $632M | $577M | $530M | $533M | $541M | $465M | $362M | $277M | |
| Goodwill | $1.96B | $1.67B | $1.24B | $1.11B | $982M | $692M | $143M | $143M | $186M | $620M | $519M | $272M | |
| Intangibles | $237M | $267M | $208M | $275M | $270M | $249M | $29M | $47M | $69M | $140M | $122M | $89M | |
| Other Non-current Assets | $147M | $138M | $143M | $123M | $179M | $119M | $105M | $24M | $141M | $41M | $28M | $30M | |
| Total Assets | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B | $6.58B | $4.43B | |
| Accounts Payable | $1.09B | $1.33B | $1.25B | $889M | $842M | $641M | $502M | $390M | $366M | $385M | $362M | $242M | |
| Current Liabilities | $7.37B | $7.90B | $8.17B | $6.86B | $7.05B | $4.96B | $3.27B | $4.25B | $5.56B | $4.57B | $3.82B | $2.17B | |
| Capital Leases | $56M | $68M | $85M | $77M | $99M | $42M | $48M | $197M | $198M | $198M | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $0 | $15M | $0 | $24M | |
| Other Non-current Liabilities | $173M | $120M | $124M | $104M | $140M | $119M | $90M | $44M | $61M | $42M | $37M | $34M | |
| Total Liabilities | $11.49B | $11.13B | $10.68B | $9.35B | $9.58B | $7.44B | $4.83B | $5.51B | $7.13B | $5.80B | $5.02B | $3.42B | |
| Long-term Debt | · | · | · | · | · | $2.13B | $1.25B | · | · | $1.65B | $1.41B | $690M | |
| Total Debt | $3.77B | $2.92B | $2.18B | $2.18B | $2.17B | $2.13B | $1.24B | $1.02B | $1.32B | $1.65B | $449M | $341.0K | |
| Retained Earnings | $3.60B | $4.09B | $3.89B | $2.80B | $2.40B | $1.86B | $1.78B | $1.01B | $298M | $810M | $758M | $615M | |
| AOCI | $15M | $-57M | $-82M | $-160M | $-5M | $37M | $4M | $-8M | $-5M | $-2M | $-4M | $-1M | |
| Stockholders' Equity | $4.07B | $4.50B | $4.21B | $2.96B | $2.63B | $2.10B | $1.96B | $1.65B | $1.34B | $1.65B | $1.56B | $1.01B | |
| Liabilities + Equity | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B | $6.58B | $4.43B | |
| Shares Outstanding | 51,000,000 | 56,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 59,000,000 | 62,000,000 | 62,000,000 | 60,000,000 | 57,000,000 | 56,000,000 | 50,000,000 |
현금 흐름
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $195M | $186M | $171M | $176M | $131M | $88M | $89M | $127M | $178M | $182M | $126M | $134M | |
| Stock-based Comp | $47M | $116M | $115M | $103M | $72M | $57M | $39M | $27M | $46M | $26M | $23M | $22M | |
| Deferred Tax | $43M | $53M | $-31M | $-66M | $-24M | $-19M | $10M | $-6M | $-94M | $22M | $-7M | $-2M | |
| Amort. of Intangibles | $91M | $82M | $85M | $77M | $49M | $15M | $18M | $21M | $31M | $32M | $17M | $18M | |
| Restructuring | · | · | · | · | · | · | · | $8M | $150M | · | · | · | |
| Other Non-cash | $-1.29B | $-890M | $316M | $-232M | $1.28B | $1.09B | $-448M | $-1.17B | $1.19B | $391M | $840M | $844M | |
| Operating Cash Flow | $-535M | $644M | $1.66B | $773M | $2.12B | $1.90B | $434M | $-314M | $804M | $673M | $1.12B | $1.06B | |
| CapEx | $101M | $100M | $84M | $91M | $77M | $74M | $57M | $30M | $86M | $176M | $132M | $115M | |
| Investing Cash Flow | $312M | $-464M | $-744M | $-790M | $-1.65B | $-400M | $-293M | $1.14B | $-1.06B | $-206M | $-1.42B | $-536M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $689M | $123M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $689M | $123M | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $0 | $373M | $0 | |
| Stock Repurchased | $1.00B | $1.00B | $0 | $400M | $128M | $606M | $47M | $0 | $0 | · | $0 | $0 | |
| Net Stock Activity | $-1.00B | $-1.00B | $0 | $-400M | $-128M | $-606M | $-47M | · | $0 | $0 | $373M | $0 | |
| Financing Cash Flow | $-170M | $-347M | $-58M | $-441M | $-183M | $217M | $-559M | $-1.19B | $636M | $19M | $1.08B | $79M | |
| Net Change in Cash | $-393M | $-167M | $860M | $-458M | $283M | $1.72B | $-418M | $-364M | $378M | $486M | $790M | $603M | |
| Taxes Paid | $275M | $379M | $405M | $340M | $235M | $321M | $239M | $240M | $7M | $153M | $197M | $30M | |
| Free Cash Flow | $-636M | $544M | $1.58B | $682M | $2.04B | $1.82B | $370M | $-344M | $718M | $497M | · | · | |
| Levered FCF | · | · | $1.50B | $600M | $1.95B | $1.74B | $304M | $-425M | $619M | $471M | · | · |
수익성
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 12.8% | 13.7% | 13.3% | 9.1% | 9.4% | 10.6% | · | |
| Operating Margin | 1.7% | 4.2% | 4.6% | 3.7% | 3.7% | 5.5% | 6.2% | 6.0% | -2.8% | 1.7% | 2.7% | 2.0% | |
| Net Margin | 1.0% | 2.9% | 3.2% | 2.5% | 2.4% | 3.5% | 4.4% | 3.7% | -2.6% | 0.29% | 1.0% | 0.64% | |
| Pretax Margin | 1.3% | 3.9% | 4.3% | 3.3% | 3.1% | 5.0% | 5.8% | 5.3% | -3.1% | 1.1% | 2.3% | 1.4% | |
| EBITDA Margin | 2.1% | 4.7% | 5.1% | 4.2% | 4.1% | 6.0% | 6.7% | 6.7% | -1.9% | 2.7% | 3.6% | 3.4% | |
| ROA | 3.0% | 7.7% | 8.0% | 6.5% | 6.1% | 8.2% | 10.6% | 9.0% | -6.4% | 0.74% | 2.6% | 1.7% | |
| ROE | 10.9% | 25.4% | 27.0% | 26.4% | 25.6% | 33.2% | 40.9% | 47.4% | -34.3% | 3.2% | 11.1% | 6.5% | |
| ROIC | 8.0% | 17.1% | 18.3% | 17.0% | 16.0% | 17.9% | 24.8% | 30.0% | -17.5% | 2.4% | 8.6% | 8.8% |
유동성 및 지급능력
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.6 | 1.5 | 1.5 | 1.4 | 1.6 | 1.8 | 1.5 | 1.4 | 1.3 | 1.4 | 1.5 | |
| Quick Ratio | 1.6 | 1.6 | 1.5 | 1.4 | 1.4 | 1.6 | 1.8 | 1.4 | 1.2 | 1.2 | 1.2 | 1.5 | |
| Debt / Equity | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 | 1.0 | 0.6 | 0.6 | 1.0 | 1.0 | 0.3 | 0.0 | |
| LT Debt / Equity | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 | 1.0 | 0.6 | 0.6 | 1.0 | 0.7 | · | · | |
| Interest Coverage | · | · | 14.4 | 10.7 | 8.5 | 10.6 | 12.0 | 9.8 | -4.7 | 3.0 | 5.9 | 3.4 |
효율성
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.9 | 2.7 | 2.5 | 2.6 | 2.6 | 2.4 | 2.4 | 2.4 | 2.5 | 2.5 | 2.6 | 2.6 | |
| Receivables Turnover | 13.3 | 12.7 | 12.6 | 14.3 | 14.4 | 12.6 | 12.3 | 17.2 | 21.6 | 22.6 | 23.8 | 21.6 |
주당
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $79.78 | $80.29 | $72.67 | $51.10 | · | $35.53 | $31.61 | $26.56 | $22.28 | $28.93 | $27.80 | $20.32 | |
| Revenue / Share | $858.71 | $704.51 | $586.44 | $546.56 | $473.91 | $323.72 | $262.95 | $283.63 | $355.05 | $317.54 | $253.18 | $199.97 | |
| Cash Flow / Share | $-10.11 | $11.16 | $28.61 | $13.21 | $36.16 | $31.50 | $6.67 | $-4.71 | $14.36 | $12.02 | $20.09 | $21.93 | |
| Cash / Share | $83.29 | $83.25 | $83.59 | $69.07 | · | $70.41 | $39.55 | $45.58 | $53.10 | $49.46 | $41.59 | $30.95 | |
| EPS (TTM) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 | $2.58 | $1.29 |
성장률
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 19.3% | 6.6% | 15.1% | 43.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.4% | 13.5% | 20.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -56.3% | 8.8% | 38.5% | 20.4% | 0.18% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -13.0% | 22.0% | 18.7% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -4.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -60.0% | 8.1% | 37.8% | 20.2% | -2.1% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -15.8% | 21.4% | 17.5% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -6.9% | · | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM)
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B | $16.83B | $18.89B | $19.88B | $17.78B | $14.18B | $9.67B | |
| Net Income TTM | $472M | $1.18B | $1.09B | $792M | $659M | $673M | $737M | $707M | $-512M | $52M | $143M | $62M | |
| Market Cap | $8.85B | $16.30B | $20.96B | $19.15B | · | $12.55B | $8.41B | $7.21B | $4.60B | $3.09B | $3.37B | $2.66B | |
| Enterprise Value | $4.36B | $10.23B | $14.03B | $13.82B | · | $8.65B | $5.25B | $3.72B | $209M | $161M | $-314M | $104M | |
| P/E | 19.5 | 14.3 | 19.2 | 24.4 | 28.3 | 18.9 | 11.8 | 11.0 | -8.5 | 59.0 | 23.3 | 41.5 | |
| P/S | 0.2 | 0.4 | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.4 | 0.2 | 0.2 | 0.2 | 0.3 | |
| P/B | 2.2 | 3.6 | 5.0 | 6.5 | · | 6.0 | 4.3 | 4.4 | 3.4 | 1.9 | 2.2 | 2.6 | |
| P / Tangible Book | 4.7 | 6.4 | 7.6 | 12.2 | · | 10.9 | · | · | · | · | · | · | |
| P / Cash Flow | -16.5 | 25.3 | 12.6 | 24.8 | · | 6.6 | 19.7 | -22.9 | 5.7 | 4.6 | 3.0 | 2.5 | |
| P / FCF | -13.9 | 30.0 | 13.3 | 28.1 | · | 6.9 | 22.7 | -20.9 | 6.4 | 6.2 | · | · | |
| EV / EBITDA | 4.5 | 5.4 | 8.0 | 10.2 | · | 7.4 | 4.6 | 3.0 | -0.6 | 0.3 | -0.6 | 0.3 | |
| EV / FCF | -6.9 | 18.8 | 8.9 | 20.3 | · | 4.8 | 14.2 | -10.8 | 0.3 | 0.3 | · | · | |
| EV / Revenue | 0.1 | 0.3 | 0.4 | 0.4 | · | 0.4 | 0.3 | 0.2 | 0.0 | 0.0 | -0.0 | 0.0 | |
| Earnings Yield | 5.1% | 7.0% | 5.2% | 4.1% | 3.5% | 5.3% | 8.5% | 9.1% | -11.8% | 1.7% | 4.3% | 2.4% |
손익계산서
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.87B | $10.80B | $11.38B | $11.48B | $11.43B | $11.15B | $10.50B | $10.34B | $9.88B | $9.93B | $9.05B | $8.55B | $8.33B | $8.15B | $8.22B | $7.93B | |
| Cost of Revenue | $9.44B | $9.27B | $10.14B | $10.04B | $9.83B | $9.48B | $9.00B | $8.64B | $8.37B | $8.41B | $7.45B | $7.31B | $7.04B | $6.87B | $6.99B | $6.75B | |
| SG&A Expense | $724M | $779M | $795M | $729M | $711M | $774M | $665M | $676M | $691M | $711M | $645M | $608M | $618M | $591M | $629M | $560M | |
| Operating Expenses | $10.73B | $10.71B | $11.54B | $11.34B | $11.05B | $10.71B | $10.12B | $9.87B | $9.45B | $9.51B | $8.73B | $8.19B | $7.88B | $7.69B | $8.12B | $7.59B | |
| Operating Income | $145M | $83M | $-162M | $137M | $373M | $433M | $380M | $467M | $434M | $426M | $316M | $359M | $443M | $455M | $105M | $335M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $27M | · | $27M | $27M | $28M | · | $28M | |
| Interest Income | · | · | · | · | · | · | · | $20M | $21M | $22M | · | $20M | $19M | $21M | · | $19M | |
| Other Non-op | · | · | · | · | · | · | · | · | $-28M | $-27M | · | $-27M | $-27M | $-28M | · | $-28M | |
| Pretax Income | $91M | $29M | $-214M | $88M | $325M | $390M | $346M | $438M | $406M | $399M | $289M | $332M | $416M | $427M | $78M | $307M | |
| Income Tax | $31M | $15M | $-54M | $9M | $70M | $92M | $95M | $112M | $105M | $98M | $73M | $87M | $107M | $106M | $22M | $77M | |
| Net Income | $60M | $14M | $-160M | $79M | $255M | $298M | $251M | $326M | $301M | $301M | $216M | $245M | $309M | $321M | $56M | $230M | |
| EPS (Basic) | $1.19 | $0.27 | $-2.80 | $1.51 | $4.75 | $5.47 | $4.46 | $5.67 | $5.18 | $5.21 | $3.72 | $4.24 | $5.37 | $5.58 | $0.98 | $4.00 | |
| EPS (Diluted) | $1.19 | $0.27 | $-2.79 | $1.51 | $4.75 | $5.45 | $4.43 | $5.65 | $5.17 | $5.17 | $3.69 | $4.21 | $5.35 | $5.52 | $0.96 | $3.95 | |
| Shares (Basic) | 51,100,000 | 50,900,000 | · | 52,500,000 | 53,600,000 | 54,600,000 | · | 57,600,000 | 58,100,000 | 57,900,000 | · | 57,800,000 | 57,700,000 | 57,500,000 | · | 57,600,000 | |
| Shares (Diluted) | 51,300,000 | 51,000,000 | · | 52,500,000 | 53,700,000 | 54,800,000 | · | 57,700,000 | 58,200,000 | 58,300,000 | · | 58,100,000 | 57,900,000 | 58,000,000 | · | 58,300,000 | |
| EBITDA | $145M | $122M | · | $137M | $373M | $481M | · | $467M | $434M | $471M | · | $359M | $443M | $499M | · | $335M |
대차대조표
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.99B | $5.31B | $4.25B | $4.22B | $4.50B | $4.86B | $4.66B | $4.73B | $4.35B | $4.51B | $4.85B | $5.57B | $4.91B | $4.55B | $4.01B | $4.24B | |
| Short-term Investments | $3.93B | $3.94B | $4.01B | $4.23B | $4.31B | $4.44B | $4.33B | $4.48B | $4.35B | $4.42B | · | $4.11B | $3.89B | $3.81B | · | $3.64B | |
| Receivables | $3.48B | $3.42B | $3.53B | $3.52B | $3.87B | $3.49B | $3.30B | $3.26B | $3.23B | $3.35B | · | $2.46B | $2.38B | $2.54B | · | $2.22B | |
| Prepaid Expense | $528M | $655M | $655M | $590M | $438M | $472M | $487M | $408M | $399M | $381M | · | $332M | $260M | $259M | · | $391M | |
| Current Assets | $12.93B | $13.33B | $12.44B | $12.55B | $13.11B | $13.26B | $12.77B | $12.88B | $12.33B | $12.67B | · | $12.47B | $11.44B | $11.16B | · | $10.49B | |
| PP&E (Gross) | · | · | $1.11B | · | · | · | $1.03B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $875M | · | · | · | $806M | · | · | · | · | · | · | · | · | · | |
| Goodwill | · | · | $1.96B | · | · | · | $1.67B | · | · | · | $1.24B | · | · | · | $1.11B | · | |
| Intangibles | · | · | $237M | · | · | · | $267M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $140M | $146M | $147M | $142M | $148M | $163M | $138M | $132M | $136M | $134M | · | $125M | $118M | $119M | · | $186M | |
| Total Assets | $16.00B | $16.39B | $15.56B | $15.70B | $16.21B | $16.39B | $15.63B | $15.76B | $15.19B | $15.51B | · | $14.87B | $13.66B | $13.37B | · | $12.79B | |
| Accounts Payable | $1.14B | $1.16B | $1.09B | $1.12B | $1.11B | $1.12B | $1.33B | $1.22B | $973M | $1.11B | · | $1.09B | $857M | $787M | · | $818M | |
| Current Liabilities | $7.70B | $8.19B | $7.37B | $7.48B | $7.88B | $8.15B | $7.90B | $8.34B | $7.84B | $8.51B | · | $8.49B | $7.54B | $7.61B | · | $7.24B | |
| Capital Leases | · | · | $56M | · | · | · | $68M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $179M | $176M | $173M | $174M | $167M | $155M | $120M | $122M | $122M | $124M | · | $121M | $122M | $88M | · | $118M | |
| Total Liabilities | $11.83B | $12.31B | $11.49B | $11.51B | $11.61B | $12.08B | $11.13B | $10.99B | $10.34B | $11.02B | · | $10.99B | $10.04B | $10.08B | · | $9.75B | |
| Total Debt | $3.77B | $3.77B | · | $3.66B | $3.38B | $3.57B | · | $2.33B | $2.18B | $2.18B | · | $2.18B | $2.18B | $2.18B | · | $2.17B | |
| Retained Earnings | $3.68B | $3.62B | $3.60B | $3.76B | $4.16B | $3.90B | $4.09B | $4.33B | $4.49B | $4.19B | · | $3.67B | $3.43B | $3.12B | · | $2.94B | |
| AOCI | $-16M | $-7M | $15M | $9M | $-10M | $-28M | $-57M | $-9M | $-85M | $-85M | · | $-165M | $-146M | $-125M | · | $-185M | |
| Stockholders' Equity | $4.17B | $4.08B | $4.07B | $4.19B | $4.60B | $4.31B | $4.50B | $4.77B | $4.84B | $4.49B | $4.21B | $3.88B | $3.62B | $3.29B | $2.96B | $3.04B | |
| Liabilities + Equity | $16.00B | $16.39B | $15.56B | $15.70B | $16.21B | $16.39B | $15.63B | $15.76B | $15.19B | $15.51B | · | $14.87B | $13.66B | $13.37B | · | $12.79B | |
| Shares Outstanding | 52,000,000 | 52,000,000 | 51,000,000 | 51,000,000 | 54,000,000 | 54,000,000 | 56,000,000 | 57,000,000 | 59,000,000 | 59,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 |
현금 흐름
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $40M | $39M | $44M | $45M | $58M | $48M | $48M | $47M | $46M | $45M | $43M | $42M | $42M | $44M | $47M | $45M | |
| Stock-based Comp | $26M | $33M | $20M | $-3M | $3M | $27M | $18M | $30M | $32M | $36M | $27M | $33M | $30M | $25M | $23M | $23M | |
| Other Non-cash | · | $996M | · | · | · | $-183M | · | · | · | $-168M | · | · | · | $526M | · | · | |
| Operating Cash Flow | $-294M | $1.08B | $-298M | $-125M | $-302M | $190M | $-224M | $873M | $-219M | $214M | $-690M | $949M | $487M | $916M | $-212M | $254M | |
| CapEx | $30M | $27M | $-1M | $38M | $42M | $22M | $11M | $35M | $27M | $27M | $-5M | $26M | $31M | $32M | $10M | $31M | |
| Investing Cash Flow | $-30M | $11M | $230M | $77M | $128M | $-123M | $19M | $-48M | $53M | $-488M | $-25M | $-280M | $-137M | $-302M | $148M | $-347M | |
| Stock Repurchased | $0 | $0 | $0 | $500M | $0 | $500M | $500M | $500M | $0 | $0 | $0 | $0 | · | · | $200M | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-500M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-4M | $-20M | $92M | $-220M | $-189M | $147M | $67M | $-364M | $12M | $-62M | $3M | $-6M | $10M | $-65M | $-183M | $10M | |
| Net Change in Cash | $-328M | $1.07B | $24M | $-268M | $-363M | $214M | $-138M | $461M | $-154M | $-336M | $-712M | $663M | $360M | $549M | $-247M | $-83M | |
| Free Cash Flow | · | $1.05B | · | · | · | $168M | · | · | · | $187M | · | · | · | $884M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $167M | · | · | · | $863M | · | · |
수익성
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 1.3% | 0.77% | · | 1.2% | 3.3% | 3.9% | · | 4.5% | 4.4% | 4.3% | · | 4.2% | 5.3% | 5.6% | · | 4.2% | |
| Net Margin | 0.55% | 0.13% | · | 0.69% | 2.2% | 2.7% | · | 3.1% | 3.0% | 3.0% | · | 2.9% | 3.7% | 3.9% | · | 2.9% | |
| Pretax Margin | 0.84% | 0.27% | · | 0.77% | 2.8% | 3.5% | · | 4.2% | 4.1% | 4.0% | · | 3.9% | 5.0% | 5.2% | · | 3.9% | |
| EBITDA Margin | 1.3% | 1.1% | · | 1.2% | 3.3% | 4.3% | · | 4.5% | 4.4% | 4.7% | · | 4.2% | 5.3% | 6.1% | · | 4.2% | |
| ROA | 0.37% | 0.09% | · | 0.50% | 1.6% | 1.9% | · | 2.1% | 2.1% | 2.1% | · | 1.8% | 2.4% | 2.5% | · | 1.9% | |
| ROE | 1.4% | 0.33% | · | 1.8% | 5.4% | 6.8% | · | 7.5% | 7.1% | 7.7% | · | 7.1% | 9.6% | 10.6% | · | 8.3% | |
| ROIC | 1.2% | 0.51% | · | 1.6% | 3.7% | 4.2% | · | 4.9% | 4.6% | 4.8% | · | 4.4% | 5.7% | 6.3% | · | 4.8% |
유동성 및 지급능력
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.6 | · | 1.7 | 1.7 | 1.6 | · | 1.5 | 1.6 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | |
| Quick Ratio | 1.6 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.5 | 1.4 | · | 1.4 | |
| Debt / Equity | 0.9 | 0.9 | · | 0.9 | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.9 | 0.9 | · | 0.9 | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 15.8 | · | 13.3 | 16.4 | 16.2 | · | 12.0 |
효율성
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.6 | 0.6 | · | 0.7 | |
| Receivables Turnover | 3.0 | 3.1 | · | 3.4 | 3.2 | 3.3 | · | 3.6 | 3.5 | 3.4 | · | 3.7 | 3.6 | 3.5 | · | 3.8 |
주당
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $80.21 | $78.46 | · | $82.18 | $85.24 | $79.81 | · | $83.68 | $82.08 | $76.15 | · | $66.88 | $62.43 | $56.69 | · | $52.43 | |
| Revenue / Share | $211.97 | $211.69 | · | $218.61 | $212.79 | $203.41 | · | $179.20 | $169.76 | $170.34 | · | $147.13 | $143.82 | $140.50 | · | $135.97 | |
| Cash Flow / Share | · | $21.22 | · | · | · | $3.47 | · | · | · | $3.67 | · | · | · | $15.79 | · | · | |
| Cash / Share | $95.87 | $102.19 | · | $82.76 | $83.31 | $89.93 | · | $83.02 | $73.80 | $76.49 | · | $95.95 | $84.66 | $78.52 | · | $73.14 | |
| EPS (TTM) | $0.18 | $3.74 | · | $16.14 | $20.28 | $20.70 | · | $19.68 | $18.24 | $18.42 | · | $16.04 | $15.78 | $14.68 | · | $14.33 |
가치 평가 (TTM)
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.52B | $45.08B | · | $44.55B | $43.41B | $41.87B | · | $39.20B | $37.41B | $35.85B | · | $33.25B | $32.63B | $32.35B | · | $31.16B | |
| Net Income TTM | $-7M | $188M | · | $883M | $1.13B | $1.18B | · | $1.14B | $1.06B | $1.07B | · | $931M | $916M | $855M | · | $839M | |
| Market Cap | $11.89B | $6.93B | · | $9.76B | $16.09B | $17.79B | · | $19.64B | $17.54B | $24.24B | · | $19.02B | $17.47B | $15.51B | · | $19.13B | |
| Enterprise Value | $6.75B | $1.45B | · | $4.98B | $10.65B | $12.07B | · | $12.76B | $11.02B | $17.48B | · | $11.52B | $10.85B | $9.33B | · | $13.42B | |
| P/E | 1270.6 | 35.6 | · | 11.9 | 14.7 | 15.9 | · | 17.5 | 16.3 | 22.3 | · | 20.4 | 19.1 | 18.2 | · | 23.0 | |
| P/S | 0.3 | 0.2 | · | 0.2 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.7 | · | 0.6 | 0.5 | 0.5 | · | 0.6 | |
| P/B | 2.9 | 1.7 | · | 2.3 | 3.5 | 4.1 | · | 4.1 | 3.6 | 5.4 | · | 4.9 | 4.8 | 4.7 | · | 6.3 | |
| P / Tangible Book | 2.9 | 1.7 | · | 2.3 | 3.5 | 4.1 | · | 4.1 | 3.6 | 5.4 | · | 4.9 | 4.8 | 4.7 | · | 6.3 | |
| P / Cash Flow | · | 6.4 | · | · | · | 93.6 | · | · | · | 113.3 | · | · | · | 16.9 | · | · | |
| EV / Revenue | 0.2 | 0.0 | · | 0.1 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.5 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | |
| Earnings Yield | 0.08% | 2.8% | · | 8.4% | 6.8% | 6.3% | · | 5.7% | 6.1% | 4.5% | · | 4.9% | 5.2% | 5.5% | · | 4.3% |
최신 기간은 왼쪽에 · null 값은 ·로 표시
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
| 지표 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 매출 | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B |
| 영업이익률 % | 1.7% | 4.2% | 4.6% | 3.7% | 3.7% |
| 순이익 | $472M | $1.18B | $1.09B | $792M | $659M |
| 희석 EPS | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 |
| 지표 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 |
| 유동비율 | 1.7 | 1.6 | 1.5 | 1.5 | 1.4 |
| 당좌 비율 | 1.6 | 1.6 | 1.5 | 1.4 | 1.4 |
| 지표 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-636M | $544M | $1.58B | $682M | $2.04B |
기관 투자자 (13F) 675개의 제출자 · $13.8B 전체 · 기준일 2026년 9월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 159 (+18 이전 분기 대비) | 68 (-75 이전 분기 대비) | 219 (+23 이전 분기 대비) | 181 (+8 이전 분기 대비) | +1.1M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| BlackRock, Inc. | $1,503,052,088 | 6,572,156 | 10.91% | 주식 |
| VANGUARD GROUP INC | $1,055,736,837 | 6,083,536 | 7.66% | 주식 |
| AQR CAPITAL MANAGEMENT LLC | $806,903,452 | 3,560,601 | 5.86% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $638,128,574 | 2,790,243 | 4.63% | 주식 |
| Capital World Investors | $586,138,203 | 2,562,913 | 4.26% | 주식 |
| Lingotto Investment Management LLP | $574,377,763 | 2,511,490 | 4.17% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $538,648,191 | 2,355,261 | 3.91% | 주식 |
| FMR LLC | $427,964,063 | 1,871,290 | 3.11% | 주식 |
| VICTORY CAPITAL MANAGEMENT INC | $427,014,918 | 1,867,140 | 3.10% | 주식 |
| STATE STREET CORP | $401,475,303 | 1,755,467 | 2.91% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $318,659,985 | 1,393,338 | 2.31% | 주식 |
| GOLDMAN SACHS GROUP INC | $298,810,862 | 1,306,563 | 2.17% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $289,810,242 | 1,267,207 | 2.10% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $289,611,501 | 1,266,338 | 2.10% | 주식 |
| Capital Research Global Investors | $249,797,804 | 1,092,251 | 1.81% | 주식 |
| MORGAN STANLEY | $230,316,927 | 1,007,068 | 1.67% | 주식 |
| HARRIS ASSOCIATES L P | $218,980,250 | 957,500 | 1.59% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $204,005,369 | 891,772 | 1.48% | 주식 |
| 8 KNOTS MANAGEMENT, LLC | $198,942,438 | 1,146,378 | 1.44% | 주식 |
| MANNING & NAPIER ADVISORS LLC | $152,338,582 | 663,669 | 1.11% | 주식 |
| UBS Group AG | $142,749,967 | 624,180 | 1.04% | 주식 |
| Long Focus Capital Management, LLC | $139,507,000 | 610,000 | 1.01% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $131,512,792 | 575,045 | 0.95% | 주식 |
| TWO SIGMA ADVISERS, LP | $116,582,437 | 671,790 | 0.85% | 주식 |
| Invesco Ltd. | $116,332,600 | 508,669 | 0.84% | 주식 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $115,548,617 | 505,241 | 0.84% | 주식 |
| NORTHERN TRUST CORP | $88,292,838 | 386,064 | 0.64% | 주식 |
| NORGES BANK | $87,054,426 | 380,649 | 0.63% | 주식 |
| Bank of New York Mellon Corp | $86,138,019 | 376,642 | 0.63% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $82,789,400 | 362,000 | 0.60% | 풋 옵션 |
| BNP PARIBAS FINANCIAL MARKETS | $82,559,556 | 360,995 | 0.60% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $75,497,758 | 330,117 | 0.55% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $72,051,935 | 315,050 | 0.52% | 주식 |
| BANK OF AMERICA CORP /DE/ | $71,479,956 | 312,549 | 0.52% | 주식 |
| Amundi | $59,944,786 | 262,111 | 0.44% | 주식 |
| PRINCIPAL FINANCIAL GROUP INC | $57,795,692 | 252,714 | 0.42% | 주식 |
| Maple Rock Capital Partners Inc. | $55,642,710 | 243,300 | 0.40% | 주식 |
| Russell Investments Group, Ltd. | $53,133,740 | 232,165 | 0.39% | 주식 |
| INVESTMENT MANAGEMENT ASSOCIATES INC /ADV | $52,660,005 | 230,258 | 0.38% | 주식 |
| STATE OF MICHIGAN RETIREMENT SYSTEM | $51,238,863 | 224,044 | 0.37% | 주식 |
| D. E. Shaw & Co., Inc. | $47,575,775 | 208,027 | 0.35% | 주식 |
| CITIGROUP INC | $47,390,070 | 207,215 | 0.34% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $46,357,490 | 202,700 | 0.34% | 콜 옵션 |
| REDWOOD CAPITAL MANAGEMENT, LLC | $45,740,000 | 200,000 | 0.33% | 주식 |
| DEUTSCHE BANK AG\ | $45,272,766 | 197,957 | 0.33% | 주식 |
| INVESTMENT HOUSE LLC | $44,310,854 | 193,751 | 0.32% | 주식 |
| JANE STREET GROUP, LLC | $43,224,300 | 189,000 | 0.31% | 풋 옵션 |
| Fiera Capital Corp | $43,130,075 | 188,588 | 0.31% | 주식 |
| Summit Street Capital Management, LLC | $41,630,489 | 182,031 | 0.30% | 주식 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $41,211,511 | 180,199 | 0.30% | 주식 |
행동주의자 및 5% 이상 소유자 1 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Mary R. Molina Living Trust, Exempt Mary R. Molina Living Trust, Mary R. Molina Grantor Retained Annuity Trust 609/4, Mary R. Molina Grantor Retained Annuity Trust 609/7, Mary R. Molina Grantor Retained Annuity Trust 1209/3, Mary R. Molina Grantor Retained Annuity Trust 1209/4, Mary R. Molina Grantor Retained Annuity Trust 610/4, Mary R. Molina Grantor Retained Annuity Trust 610/5, Mary R. Molina Grantor Retained Annuity Trust 1210/4, Mary R. Molina Grantor Retained Annuity Trust 811/3, Mary R. Molina Grantor Retained Annuity Trust 812/3, Estate of Mary R. Molina, Dentino Family Trust, Curtis and Rosi Pedersen 2012 Trust, William Dentino, Curtis Pedersen ×3 제출 서류 | 2018년 1월 23일 | · | 최초 제출 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
회사 내부자 62 명의 내부자 · 25 임원 · 19 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Roman Kulich | Pres & CEO of Molina of MI | 2007년 8월 22일 S | 5,734 | 0 | 0 | $0 |
| Gerald Landgraf | CEO/Pres of Molina of NM | 2005년 7월 1일 A | · | 0 | 0 | $0 |
| Mark Lowell Keim | Chief Financial Officer | 2026년 3월 1일 A | 83,251 | 0 | 0 | $0 |
| Joseph W White CPA | Former Chief Financial Officer | 2018년 6월 6일 D | 48,390 | 0 | 0 | $0 |
| James Woys | Chief Operating Officer | 2026년 6월 30일 A | 90,178 | 0 | 0 | $0 |
| Terry Bayer | Chief Operating Officer | 2018년 2월 2일 D | 28,730 | 0 | 0 | $0 |
| Debra Bacon | EVP, Medicaid | 2026년 7월 1일 F | 21,636 | 0 | 0 | $0 |
| Jeff D. Barlow | Chief Legal Officer | 2026년 6월 30일 A | 67,313 | 0 | 1 | $-3,314,983 |
| Marc Russo | EVP, Health Plans | 2023년 8월 7일 S | 37,093 | 0 | 0 | $0 |
| Pamela Sedmak | Executive Vice President | 2020년 3월 1일 F | 8,846 | 0 | 0 | $0 |
| Lisa A Rubino | Senior Vice President | 2018년 3월 1일 F | 25,084 | 0 | 0 | $0 |
| Keith Wilson | Chief Medical Officer | 2017년 6월 30일 A | 29,441 | 0 | 0 | $0 |
| Amir Desai | Chief Information Officer | 2010년 8월 16일 S | 16,782 | 0 | 0 | $0 |
| Mark L Andrews ESQ | Exec. VP, General Counsel | 2010년 7월 1일 F | 51,006 | 0 | 0 | $0 |
| Mary Martha Bernadett MD | Exec. V.P., Research | 2008년 12월 5일 J | 50,000 | 0 | 0 | $0 |
| Stephen T O'Dell | Regional Vice President | 2008년 8월 7일 F | 16,199 | 0 | 0 | $0 |
| Lillis Ann Koontz | Regional Vice President | 2008년 6월 30일 A | 15,304 | 0 | 0 | $0 |
| George Kirk Olsen | VP, Molina Advantage | 2007년 6월 29일 A | 7,822 | 0 | 0 | $0 |
| Michael M Siegel | Chief Medical Officer | 2007년 3월 1일 A | 5,150 | 0 | 0 | $0 |
| Rick Click | Chief Information Officer | 2007년 3월 1일 A | 8,500 | 0 | 0 | $0 |
| Harvey A Fein | VP, Internal Auditing | 2007년 3월 1일 A | 8,713 | 0 | 0 | $0 |
| Joann Zarza-Garrido | VP, Compliance | 2007년 2월 28일 S | 4,774 | 0 | 0 | $0 |
| William Bracciodieta | Former Chief Medical Officer | 2007년 2월 16일 F | 5,000 | 0 | 0 | $0 |
| Sheila Shapiro | Exec. VP, Shared Services | 2005년 12월 30일 J | 12,564 | 0 | 0 | $0 |
| Jennings Patricia Dinsmore | VP Qual. Op. & Integration | 2004년 8월 16일 S | 0 | 0 | 0 | $0 |
| Stephen H Lockhart | 이사 | 2026년 10월 1일 A | 4,688 | 0 | 0 | $0 |
| Richard M Schapiro | 이사 | 2026년 10월 1일 A | 12,615 | 0 | 1 | $-51,058 |
| Richard C Zoretic | 이사 | 2026년 10월 1일 A | 9,693 | 1 | 0 | $100,128 |
| Leo P Grohowski | 이사 | 2026년 10월 1일 A | 1,846 | 0 | 0 | $0 |
| Francis S Soistman JR | 이사 | 2026년 10월 1일 A | 1,211 | 0 | 0 | $0 |
| Dale B Wolf | 이사 | 2026년 10월 1일 A | 15,937 | 0 | 0 | $0 |
| Steven J Orlando | 이사 | 2026년 10월 1일 A | 18,271 | 0 | 0 | $0 |
| Ronna Romney | 이사 | 2026년 10월 1일 A | 18,173 | 0 | 1 | $-74,342 |
| Barbara L Brasier | 이사 | 2026년 10월 1일 A | 6,122 | 0 | 0 | $0 |
| Daniel Cooperman | 이사 | 2025년 4월 1일 A | 6,383 | 0 | 0 | $0 |
| Garrey Carruthers | 이사 | 2021년 4월 1일 A | 5,265 | 0 | 0 | $0 |
| Charles Z Fedak | 이사 | 2019년 4월 1일 A | 19,092 | 0 | 0 | $0 |
| John C Molina | 이사 | 2018년 2월 20일 S | 372,930 | 0 | 0 | $0 |
| Frank E Murray MD | 이사 | 2017년 10월 1일 A | 16,811 | 0 | 0 | $0 |
| Steven James | 이사 | 2016년 4월 1일 A | 15,024 | 0 | 0 | $0 |
| John P Szabo JR | 이사 | 2015년 4월 1일 A | 17,097 | 0 | 0 | $0 |
| Sally K Richardson | 이사 | 2012년 5월 3일 A | 47,537 | 0 | 0 | $0 |
| Wayne B Lowell | 이사 | 2007년 5월 10일 A | 10,011 | 0 | 0 | $0 |
| Ronald Cpa Dba Lossett | 이사 | 2004년 2월 10일 A | · | 0 | 0 | $0 |
| MARY R MOLINA LIVING TRUST | 10% 소유주 | 2009년 12월 14일 J | 2,137,134 | 0 | 0 | $0 |
| MOLINA MARITAL TRUST | 10% 소유주 | 2006년 6월 22일 S | 2,926,907 | 0 | 0 | $0 |
| Maurice Hebert | · | 2026년 5월 14일 S | 12,815 | 0 | 1 | $-114,930 |
| Joseph M Zubretsky | · | 2026년 3월 1일 A | 99,015 | 0 | 0 | $0 |
| Thomas L Tran | · | 2021년 5월 24일 F | 29,775 | 0 | 0 | $0 |
| Norman Nichols | · | 2018년 8월 8일 S | 47,415 | 0 | 0 | $0 |
| Harold Gooch | · | 2018년 6월 30일 A | 7,063 | 0 | 0 | $0 |
| Mario J Molina MD | · | 2017년 12월 11일 S | 61,125 | 0 | 0 | $0 |
| James W Howatt | · | 2010년 3월 19일 S | 34,081 | 0 | 0 | $0 |
| Curtis Pedersen | · | 2009년 11월 5일 G | 1,200 | 0 | 0 | $0 |
| Josephine M Molina | · | 2008년 8월 6일 J | 345,701 | 0 | 0 | $0 |
| Janet M Watt | · | 2008년 8월 6일 J | 284,641 | 0 | 0 | $0 |
| Josephine M Battiste | · | 2008년 8월 6일 J | 345,701 | 0 | 0 | $0 |
| Zarina Sparling | · | 2008년 2월 21일 M | 9,380 | 0 | 0 | $0 |
| Mary R Molina | · | 2006년 9월 27일 J | 0 | 0 | 0 | $0 |
| George S Goldstein PHD | · | 2006년 5월 11일 M | 0 | 0 | 0 | $0 |
| Richard A Helmer MD | · | 2005년 6월 30일 J | 1,908 | 0 | 0 | $0 |
| David W Erickson | · | 2004년 12월 2일 M | 0 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
ETF 보유 현황 73 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| SOVF · Elevation Series Trust | 4.23% | 18,894 NS | 2026년 7월 31일 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 1.81% | 120,017 SH | 2026년 10월 1일 | 일간 |
| RFV · Invesco Exchange-Traded Fund Trust | 1.77% | 29,907 SH | 2026년 10월 1일 | 일간 |
| IHF · iShares Trust | 1.53% | 100,080 SH | 2026년 9월 11일 | 일간 |
| VIOV · VANGUARD ADMIRAL FUNDS | 1.28% | 110,553 SH | 2026년 8월 19일 | 일간 |
| BSJS · Invesco Exchange-Traded Self-Indexe… | 0.76% | 5,983,000 | 2026년 10월 1일 | 일간 |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.64% | 182,154 SH | 2026년 8월 19일 | 일간 |
| FFLV · FIDELITY COVINGTON TRUST | 0.41% | 343 NS | 2026년 7월 31일 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0.40% | 6,790 NS | 2026년 7월 31일 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0.33% | 7,103 SH | 2026년 10월 1일 | 일간 |
| DFAT · Dimensional ETF Trust | 0.27% | 198,247 NS | 2026년 7월 31일 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0.26% | 8,610 NS | 2026년 7월 31일 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.25% | 758,589 SH | 2026년 8월 19일 | 일간 |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.22% | 22,626 NS | 2026년 7월 31일 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0.22% | 765 NS | 2026년 7월 31일 | N-PORT |
| PTMC · Pacer Funds Trust | 0.20% | 3,918 NS | 2026년 7월 31일 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.18% | 156,577 SH | 2026년 8월 19일 | 일간 |
| ESML · iShares Trust | 0.17% | 23,899 SH | 2026년 9월 11일 | 일간 |
| IYH · iShares Trust | 0.17% | 30,059 SH | 2026년 9월 11일 | 일간 |
| DFSV · Dimensional ETF Trust | 0.16% | 67,624 NS | 2026년 7월 31일 | N-PORT |
| ISCG · iShares Trust | 0.16% | 7,446 SH | 2026년 9월 11일 | 일간 |
| FHLC · FIDELITY COVINGTON TRUST | 0.15% | 24,870 NS | 2026년 7월 31일 | N-PORT |
| SMMD · iShares Trust | 0.14% | 27,458 SH | 2026년 9월 11일 | 일간 |
| VB · VANGUARD INDEX FUNDS | 0.14% | 1,195,007 SH | 2026년 8월 19일 | 일간 |
| VXF · VANGUARD INDEX FUNDS | 0.13% | 597,850 SH | 2026년 8월 19일 | 일간 |
| IWS · iShares Trust | 0.10% | 77,233 SH | 2026년 9월 11일 | 일간 |
| WSML · iShares Trust | 0.10% | 3,305 SH | 2026년 9월 11일 | 일간 |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.10% | 4,920 SH | 2026년 10월 1일 | 일간 |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.09% | 3,768 SH | 2026년 10월 1일 | 일간 |
| DFAS · Dimensional ETF Trust | 0.09% | 68,863 NS | 2026년 7월 31일 | N-PORT |
| IWR · iShares Trust | 0.08% | 210,604 SH | 2026년 9월 11일 | 일간 |
| PRF · Invesco Exchange-Traded Fund Trust | 0.07% | 35,013 SH | 2026년 10월 1일 | 일간 |
| EMGF · iShares, Inc. | 0.06% | 15,805 SH | 2026년 9월 11일 | 일간 |
| DXUV · Dimensional ETF Trust | 0.05% | 1,409 NS | 2026년 7월 31일 | N-PORT |
| EMXC · iShares, Inc. | 0.05% | 162,911 SH | 2026년 9월 11일 | 일간 |
| DFSU · Dimensional ETF Trust | 0.04% | 5,157 NS | 2026년 7월 31일 | N-PORT |
| VEGN · ETF Series Solutions | 0.03% | 305 NS | 2026년 7월 31일 | N-PORT |
| IUSV · iShares Trust | 0.03% | 45,470 SH | 2026년 9월 11일 | 일간 |
| IEMG · iShares, Inc. | 0.03% | 689,771 SH | 2026년 9월 11일 | 일간 |
| EEM · iShares, Inc. | 0.03% | 131,827 SH | 2026년 9월 11일 | 일간 |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 31,058 SH | 2026년 8월 19일 | 일간 |
| IWD · iShares Trust | 0.03% | 114,206 SH | 2026년 9월 11일 | 일간 |
| DFUV · Dimensional ETF Trust | 0.03% | 20,443 NS | 2026년 7월 31일 | N-PORT |
| DYNF · BlackRock ETF Trust | 0.03% | 52,472 SH | 2026년 9월 11일 | 일간 |
| TILT · FlexShares Trust | 0.02% | 2,686 NS | 2026년 7월 31일 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.02% | 1,655,258 SH | 2026년 8월 19일 | 일간 |
| VWO · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.02% | 868,836 SH | 2026년 8월 19일 | 일간 |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.02% | 8,548 SH | 2026년 8월 19일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.02% | 4,354 SH | 2026년 8월 19일 | 일간 |
| ESGV · VANGUARD WORLD FUND | 0.02% | 11,634 SH | 2026년 8월 19일 | 일간 |
| DFAC · Dimensional ETF Trust | 0.02% | 45,023 NS | 2026년 7월 31일 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.02% | 2,946 NS | 2026년 7월 31일 | N-PORT |
| IXUS · iShares Trust | 0.02% | 126,782 SH | 2026년 9월 11일 | 일간 |
| IWV · iShares Trust | 0.01% | 14,718 SH | 2026년 9월 11일 | 일간 |
| IWB · iShares Trust | 0.01% | 35,396 SH | 2026년 9월 11일 | 일간 |
| IYY · iShares Trust | 0.01% | 2,168 SH | 2026년 9월 11일 | 일간 |
| DFUS · Dimensional ETF Trust | 0.01% | 15,184 NS | 2026년 7월 31일 | N-PORT |
| ITOT · iShares Trust | 0.01% | 67,059 SH | 2026년 9월 11일 | 일간 |
| DFAU · Dimensional ETF Trust | 0.01% | 8,285 NS | 2026년 7월 31일 | N-PORT |
| NEAR · iShares U.S. ETF Trust | 0.01% | 531,000 SH | 2026년 9월 11일 | 일간 |
| VOXP · Advisors Series Trust | 0.01% | 3 NS | 2026년 7월 31일 | N-PORT |
| ACWX · iShares Trust | 0.01% | 16,724 SH | 2026년 9월 11일 | 일간 |
| VXUS · VANGUARD STAR FUNDS | 0.01% | 910,737 SH | 2026년 8월 19일 | 일간 |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 145,760 SH | 2026년 8월 19일 | 일간 |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 89,282 SH | 2026년 8월 19일 | 일간 |
| VYMI · VANGUARD WHITEHALL FUNDS | 0.01% | 68,906 SH | 2026년 8월 19일 | 일간 |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.01% | 2,303 SH | 2026년 10월 1일 | 일간 |
| ACWI · iShares Trust | 0.00% | 8,307 SH | 2026년 9월 11일 | 일간 |
| IJH · iShares Trust | · | 1,828,162 SH | 2026년 9월 11일 | 일간 |
| IJJ · iShares Trust | · | 265,658 SH | 2026년 8월 21일 | 일간 |
| ISCB · iShares Trust | · | 2,352 SH | 2026년 9월 11일 | 일간 |
| ISCV · iShares Trust | · | 6,481 SH | 2026년 9월 11일 | 일간 |
| SMMV · iShares Trust | · | 4,872 SH | 2026년 9월 1일 | 일간 |
MOH 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
12개월 목표 주가
17 명의 애널리스트 · 2026-09-30평균 목표 $209.12 +10.3%
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
회계연도 기준, 각 회사의 마지막 회계연도 말 종가 기준 가격입니다.
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요. 상단의 전체 기본 정보에서 원하는 행 옆의 +를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.